Navigation Links
Three Executives from inVentiv Health Clinical and Communications Recognized on Prestigious List of PharmaVOICE 100 Industry Leaders
Date:8/6/2013

BURLINGTON, Mass., Aug. 6, 2013 /PRNewswire/ -- inVentiv Health, offering best-in-class clinical, commercial and consulting services, today congratulated three executives from its clinical and communications businesses named to the PharmaVOICE 100 list for their exemplary innovation within the healthcare industry.

John Guarino from Palio+Ignite, Tim McCort from GSW Fueled by Blue Diesel, and Pam Strobel from inVentiv Health Clinical were all recognized on a list that includes "extraordinary leaders, innovators, game changers, researchers and scientists, clinical experts, technologists, patient advocates and mentors."

"All three of these people are thought leaders, innovators in their fields and reflect the excellence found across the 13,000 people worldwide who work for inVentiv Health," said inVentiv Health CEO Paul Meister. "We congratulate John, Tim and Pam on this well-deserved industry recognition."

PharmaVoice calls Guarino, who has more than two decades of industry experience, a managed markets communications "guru." "In less than three years, he has built a managed markets team at Palio+Ignite Managed Markets that is a force to be reckoned with," the magazine said. As Executive Vice President Managed Markets and Global Payer Access, Guarino makes sure his team on two coasts is well-tuned on reimbursement, effective pull-through, specialty drugs and specialty pharmacy and contracting profitability. They understand the differences and similarities between traditional marketing and payer marketing, which allows them to deliver strategies and tactics that ensure access and reimbursement success critical to the brands they are managing.

Among Guarino's innovations is the launch of a blog series called Managed Markets Monday focused on sharing insights on comparative effectiveness research, Medicare Part D and the Affordable Care Act. "John knows that marketing strategies must keep pace with how healthcare delivery is changing and that the success of a brand today depends on understanding the managed market environment," Meister said.

McCort was recognized by PharmaVoice as a master storyteller who says he walks into every meeting believing there is a 50% or greater chance that he is wrong - which forces him to listen.  Early in his career, McCort built powerhouse campaigns for major consumer brands such as McDonald's before turning his skills to take on one of the nation's biggest challenges, helping more people choose to actively improve their health. Today, as Executive Vice President and General Manager of GSW, he is a key leader of the agency's diabetes practice and says that in health, it is not enough for marketing to sell products, marketing must also help people be successful in changing their own lives. The biggest competitors for healthcare brands aren't other brands. The real competitors are lack of knowledge, lack of motivation, inaction and the frailties of being human. "Tim has delved deeply into the emerging science of behavior change to inform the very human approach he takes to solving client communications challenges," Meister said. "It is not surprising that he has become the go-to person for clients seeking the best consumer campaigns in the business."

As Executive Director of Strategic Resourcing Quality at inVentiv Clinical, Strobel creates initiatives to build process improvements around the quality of clinical trial data in real time.  Strobel introduced a centralized remote data review team to improve the efficiency and compliance of monitoring patient visit data for a large pharmaceutical client. Through this, her team was able to quickly identify and resolve quality and safety issues, as well as protocol deviations. Among her other accomplishments is the creation of a quality dashboard tracking system that tracks client audits/assessments, protocol deviations, issue escalation, training compliance and regulatory inspections for each of FSPs in real time. The dashboard allows her to see trends across a single client, as well as all clients, where she can recommend process improvements. 

"Faced with increasing pressure to minimize waste and reduce development costs, pharmaceutical clients will be looking for an improved risk-management approach that relies on proactive quality measures," Meister said. "Pam is an innovator in quality, well ahead of the curve and proactive in a field that is, by nature, retrospective," Meister said.

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life. In 40 countries around the world, inVentiv's 13,000 employees help clients rapidly transform promising ideas into commercial reality. inVentiv clients include more than 550 pharmaceutical, biotech and life sciences companies, as well as companies that now see health as part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inVentivHealth.com.   


'/>"/>
SOURCE inVentiv Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. inVentiv Health Clinical Expands and Strengthens Executive Team with Three Strategic Appointments
2. Elusys Releases New Data On Anthrax Anti-Toxin Administered Via Intramuscular Injection From Three Recent Animal Studies
3. Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider Network
4. Sigma-Aldrich Corporation Presentations At Three Upcoming Conferences To Be Webcast Live
5. ICO Honors Three with Awards during SPIE Optics and Optoelectronics
6. At Three Months Post Launch, Two-Thirds of Surveyed U.S. Rheumatologists Believe that Initiations of Pfizers Xeljanz in the Rheumatoid Arthritis Treatment Algorithm Will Occur Following at Least Two Biologic Failures
7. Cancer Advances Announces Issuance of Three New Patents to Its Suite of Gastrin Inhibitor Products
8. Three Dispensing Modes Featured in the New Masterflex I/P Digital Brushless Process Drives from Cole-Parmer
9. NSF International Promotes Three Leaders and Scientific Experts to Key Global Positions
10. Three-Step Rust Removal With a Non-Invasive Rust Remover Published by My Cleaning Products, MCP Offers Sample of the Product
11. Growing Uptake of Genzymes Aubagio at Three Months Post-Launch Is Likely Driven by Perceived Product Convenience Even As Neurologists Search to Identify Appropriate Candidates, According to a Recent BioTrends Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):